Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 284
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01536886 | LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris | ||
| NCT02310646 | Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris | ||
| NCT01707368 | Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation | ||
| NCT01105234 | An Irritation Study With New Calcipotriol Ointment Formulations in Healthy Subjects | ||
| NCT06884163 | Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell Proteomics | ||
| NCT01310049 | LEO 32731 - A Study in Healthy Male Subjects | ||
| NCT00986856 | Fucidin® Cream in the Treatment of Impetigo | ||
| NCT00051532 | Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma | ||
| NCT03683719 | Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema | ||
| NCT03673527 | Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin | ||
| NCT03054727 | Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT ) | ||
| NCT00185510 | Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis | ||
| NCT02636101 | Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study | ||
| NCT01043224 | A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris | ||
| NCT02627989 | An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids | ||
| NCT05194540 | Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA) | ||
| NCT01848028 | PsoBest - The German Psoriasis Registry | ||
| NCT03402828 | Body PSOriasis: Long-term Relapse CONTROL | ||
| NCT01387711 | PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology | ||
| NCT01083758 | Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis | ||
| NCT05682976 | Ophthalmological Adverse Events of Tralokinumab in AD | ||
| NCT01701843 | Cromoglicate in Mastocytosis | ||
| NCT01998984 | Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis | ||
| NCT01302925 | PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects | ||
| NCT05259722 | A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema | ||
| NCT02120456 | Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis | ||
| NCT01946386 | A Vasoconstriction Study With LEO 90100 | ||
| NCT02547363 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up | ||
| NCT03131648 | Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) | ||
| NCT02038569 | An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects | ||
| NCT05938478 | Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT | ||
| NCT03587805 | Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND | ||
| NCT05625932 | TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer | ||
| NCT02392130 | A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin | ||
| NCT01447758 | Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis. | ||
| NCT01423656 | Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102 | ||
| NCT00833872 | LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects | ||
| NCT00758862 | The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo | ||
| NCT00216879 | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis | ||
| NCT00475605 | A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis | ||
| NCT06624670 | A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum | ||
| NCT01866163 | LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris | ||
| NCT01587755 | Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP) | ||
| NCT02219633 | Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) | ||
| NCT03827876 | Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis | ||
| NCT03761537 | Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7 | ||
| NCT03336372 | Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients | ||
| NCT04794569 | Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome | ||
| NCT00051545 | Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma | ||
| NCT02549339 | Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up |
